Quality Inspection for Rapamycin - Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0%~101.0% API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

, , ,
Quality Inspection for Rapamycin - Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0%~101.0% API High Purity – Ruifu Detail:

Manufacturer with High Purity and Stable Quality
Chemical Name: Memantine Hydrochloride
Synonyms: Memantine HCl; 3,5-Dimethyl-1-adamantanamine Hydrochloride
CAS: 41100-52-1
Memantine Hydrochloride in the treatment of Alzheimer’s disease
API USP Standard, High Quality, Commercial Production

Chemical Name Memantine Hydrochloride
Synonyms Memantine HCl; 3,5-Dimethyl-1-adamantanamine Hydrochloride
CAS Number 41100-52-1
CAT Number RF-API43
Stock Status In Stock, Production Scale Up to Tons
Molecular Formula C12H22ClN
Molecular Weight 215.76
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Crystal Powder
Identification IR
Loss on Drying ≤0.50%
Heavy Metals (Pb) ≤10ppm
Residual Solvent Ethanol ≤0.05%
Residual Solvent Ethylacetate ≤0.05%
Contamination Microbiologica Max 102 aerobes and fungi per 1g
No Escherichia coli
Size of Distributed Particles Pass 100um
pH 4.5~6.5
Assay 99.0%~101.0%
Test Standard USP Standard
Usage Active Pharmaceutical Ingredient (API)

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1
2

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Memantine Hydrochloride (CAS: 41100-52-1) with high quality.
Memantine Hydrochloride (CAS: 41100-52-1) is a well- known neuroprotective drug used for the treatment of Alzheimer’s disease. It is believed to be the first neuroprotective drug that has achieve clinical approval by US FDA as well as European. The development of Alzheimer’s disease involves the misfolded mutant proteins such as β-amyloid peptide (Aβ, particularly Aβ1−42). These misfolded mutant protein can increase the NMDA response and further cause severe excitotoxicity. Memantine suppresses this process through acting as the antagonist of the N-methyl-d- aspartate-sensitive glutamate receptor (NMDARs). Memantine Hydrochloride (CAS: 41100-52-1) is also under investigation as a potential treatment for other kind of neurodegenerative disorders such as HIV-associated dementia, neuropathic pain, glaucoma, depression, Huntington’s disease, ALS and movement disorders, among other.
Memantine Hydrochloride, a NMDA receptor antagonist, was co-developed by Forest Laboratories with Merz Pharmaceuticals and marketed under the trade name Namenda for the treatment of Alzheimer’s disease in the US after its approval in October, 2003. This drug has been available in many European and Asian markets before getting approval in the US.


Product detail pictures:

Quality Inspection for Rapamycin - Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0%~101.0% API High Purity – Ruifu detail pictures


Related Product Guide:

Quality Inspection for Rapamycin - Memantine Hydrochloride Memantine HCl CAS 41100-52-1 Assay 99.0%~101.0% API High Purity – Ruifu , The product will supply to all over the world, such as: , , ,

  • 5 Stars By from -

    5 Stars By from -
    Write your message here and send it to us